Home / Street Sector / EPS Estimates Lure Passive Investments: Altria Group, Inc. (NYSE:MO), Colgate-Palmolive Co. (NYSE:CL)

EPS Estimates Lure Passive Investments: Altria Group, Inc. (NYSE:MO), Colgate-Palmolive Co. (NYSE:CL)

Altria Group, Inc. (NYSE:MO) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 0.89% to close at $62.54 with the total traded volume of 5.01 Million shares. Finally, analysts shed their light over the MO price targets; maintaining price high target of 74.00 while at average the price target was 68.27 in contrast with the current price of 62.54. The price targets are usually acts as the boosters or blasters in the performance of stock. A higher price target would definitely provide confidence to investors during the trading action, consideration given by Wall Street Journal.

So does the rankings given by analysts; let us highlight rankings table and we had 5 analyst recommending BUY ratings for current month and for previous month 5 stands on similar situation; while 7 for the current month as compared to 6 analysts recommending for HOLD from the pool for previous month. While 2 stands at overweight and 0 analysts gave Underweight and 0 out of pool consider it as Sell for current month. For the overall, consensus ratings were for Overweight.

The firm has institutional ownership of 62.30%, while insider ownership included 0.10%. Its price to sales ratio ended at 4.77. MO attains analyst recommendation of 2.20 with week performance of 2.16%.

Colgate-Palmolive Co. (NYSE:CL) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 0.32% to $72.43. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked CL in recent few months. In ratings table the CL given BUY ratings by 3 analyst in current phase and 2 analysts suggest it as overweight security. .CL. While 14 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, consensus pool recommends it as Hold security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $0.73 at current month while compared with $0.73 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.76 and on annual basis FY 2016 estimate trends at current was for $2.83 as compared to one month ago of $2.82, and for next year per share earnings estimates have $3.09.

The share price of CL attracts active investors, as stock price of week volatility recorded 1.22%. The stock is going forward to its 52-week low with 19.96% and lagging behind from its 52-week high price with -3.91%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Stocks Taking Toll on Investment Valuation: Diplomat Pharmacy (NYSE:DPLO), Tonix Pharmaceuticals (NASDAQ:TNXP)

Waking on tracing line of previous stocks, Diplomat Pharmacy, Inc. (NYSE:DPLO) also making a luring …

Leave a Reply

Your email address will not be published. Required fields are marked *